-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is known as coronavirus-19 disease ( COVID-19 ) or COVID
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is known as coronavirus-19 disease ( COVID-19 ) or COVID
The study, known as the GI-COVID-19 study, was a prospective, multicenter, controlled study
A total of 2036 hospitalized patients were included in the study
Figure: Probability of gastrointestinal symptoms in patients with new coronary pneumonia
The findings of this study confirm that the prevalence of gastrointestinal symptoms in hospitalized COVID-19-positive patients is higher than previously reported
The findings of this study confirm that the prevalence of gastrointestinal symptoms in hospitalized COVID-19-positive patients is higher than previously reported
Marasco, Giovanni.
Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study.
Leave a comment here